19 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
to address HPV+ tumors. According to the Centers for Disease Control (“CDC”) in the United States, HPV+ tumors represent 3% of all cancers in women … to the International Journal of Cancer, resulting in 570,000 new cases for women and 60,000 new cases for men globally every year. According
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
% of all cancers in women and 2% of all cancers in men, resulting in over 36,000 new cases of HPV+ tumors every year. HPV+ tumors represent 4.5% of all … cancers worldwide, according to the International Journal of Cancer, resulting in 570,000 new cases for women and 60,000 new cases for men globally every
8-K
EX-99.1
SQZB
SQZ Biotechnologies Co
6 Dec 22
Designation Represents Potential to Bring Important New Therapy to Patients Earlier
4:23pm
. According to the Centers for Disease Control (CDC), in the United States HPV+ tumors represent 3% of all cancers in women and 2% of all cancers in men
8-K
EX-99.1
SQZB
SQZ Biotechnologies Co
24 Jan 22
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
7:01am
cancers in women and 2% of all cancers in men, resulting in over 39,000 new cases of HPV+ tumors every year. HPV infection is larger outside
8-K
EX-99.1
cvxmputfn
9 Dec 21
Other Events
7:30am
8-K
EX-99.1
wp5cvx
2 Dec 21
Other Events
6:28am
8-K
EX-99.1
djkkst in
26 Oct 21
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate into Combination
6:54am
8-K
EX-99.1
rm73u
4 Jun 21
Regulation FD Disclosure
8:09am
10-K
6umyw k8l7ur8d2z
18 Mar 21
Annual report
6:31am
424B4
ajyygzk r3c1uq
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
88xeo9rklyriugvcoe3
1 Feb 21
Draft registration statement
12:00am
424B4
4vhm2l8xd8nd8c
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
9kg8v
9 Oct 20
IPO registration
4:59pm
DRS/A
jty6vtrfkpdgimj y0
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
n5v8b1 mcp
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
skwcl9g
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next